Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma

被引：0
|
作者：
Bolag Altan
Kyoichi Kaira
Akira Watanabe
Norio Kubo
Pinjie Bao
Gantumur Dolgormaa
Erkhem-Ochir Bilguun
Kenichiro Araki
Yoshikatsu Kanai
Takehiko Yokobori
Tetsunari Oyama
Masahiko Nishiyama
Hiroyuki Kuwano
Ken Shirabe
机构：
[1] Gunma University Graduate School of Medicine,Department of Oncology Clinical Development
[2] Gunma University Graduate School of Medicine,Department of Hepatobiliary and Pancreatic Surgery
[3] Gunma University Graduate School of Medicine,Department of General Surgical Science
[4] Gunma University Graduate School of Medicine,Department of Molecular Pharmacology and Oncology
[5] Osaka University,Department of Bio
[6] Gunma University Initiative for Advanced Research,system Pharmacology, Graduate School of Medicine
[7] Gunma University Graduate School of Medicine,Division of Integrated Oncology Research, Research Program for Omics
来源：
Cancer Chemotherapy and Pharmacology | 2018年 / 81卷
关键词：
LAT1; Pancreatic cancer; Prognosis; Chemotherapy; Resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：141 / 153
页数：12
相关论文
共 50 条
  • [41] CXCR2 and its ligands modulate chemotherapy resistance in pancreatic ductal adenocarcinoma.
    Molczyk, Caitlin
    Prajapati, Dipakkumar R.
    Saxena, Sugandha
    Goel, Paran
    Varney, Michelle
    Singh, Rakesh K.
    CANCER RESEARCH, 2021, 81 (13)
  • [42] Expression of large neutral amino acid transporters LAT1 and LAT2 in medulloblastoma
    Francesco Cicone
    Giuseppe Minniti
    Maria Antonietta Oliva
    Luciano Carideo
    John O. Prior
    Francesco Scopinaro
    Felice Giangaspero
    Antonietta Arcella
    Brain Tumor Pathology, 2017, 34 : 179 - 181
  • [43] Study of p53 expression in pancreatic ductal adenocarcinoma and its relationship to survival
    Lorente Gea, L.
    Azagra de Miguel, I.
    Fernandez-Vega, I.
    Camacho-Urkaray, E.
    Maestro-Gomez, L.
    Gorostiaga Altuna, I.
    Gutierrez-Corres, F. B.
    Aguirre Anda, J.
    VIRCHOWS ARCHIV, 2017, 471 : S128 - S128
  • [44] Prognostic value of large amino acid transporter type 1 (LAT1) expression in pulmonary adenocarcinoma: A tissue microarray study
    Terao, Azusa
    Ninomiya, Hironori
    Takeuchi, Kengo
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2024, 39
  • [45] Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma
    Schmiechen, Zoe C.
    Stromnes, Ingunn M.
    FRONTIERS IN IMMUNOLOGY, 2021, 11
  • [46] MUC16 expression in pancreatic ductal adenocarcinoma patient samples after neoadjuvant chemotherapy
    Muilenburg, Kathryn M.
    Ehrhorn, Evie G.
    Olson, Madeline T.
    Isder, Carly C.
    Klute, Kelsey A.
    Talmon, Geoffrey A.
    Carlson, Mark A.
    Ly, Quan P.
    Mohs, Aaron M.
    CANCER RESEARCH, 2024, 84 (02)
  • [47] Resistance signatures to oncolytic vesiculoviruses in pancreatic ductal adenocarcinoma
    Watters, Chelsae R.
    Barro, Oumar
    Gabere, Musa
    Masuda, Mia Y.
    Elliott, Natalie M.
    Raupach, Elizabeth A.
    Ferdous, Khandoker Usran
    Tesfay, Mulu Z.
    Moaven, Omeed
    Zhou, Yumei
    Barrett, Michael T.
    Buetow, Kenneth H.
    Nagalo, Bolni Marius
    Borad, Mitesh J.
    MOLECULAR THERAPY ONCOLOGY, 2025, 33 (01):
  • [48] GemcitabineAcquired resistance in pancreatic ductal adenocarcinoma: case report
    Reactions Weekly, 2018, 1697 (1) : 177 - 177
  • [49] Clinical significance of ADAM28 expression and decrease induced by chemotherapy in pancreatic ductal adenocarcinoma
    Iwasaki, Toshimitsu
    Mochizuki, Satsuki
    Nakajima, Kosei
    Kajiwara, Yoshiki
    Shinto, Eiji
    Okada, Yasunori
    Ueno, Hideki
    Kishi, Yoji
    CANCER SCIENCE, 2021, 112 : 494 - 494
  • [50] Disparities in the Use of Chemotherapy in Patients with Resected Pancreatic Ductal Adenocarcinoma
    Michael J. Wright
    Heidi N. Overton
    Jonathan A. Teinor
    Ding Ding
    Richard A. Burkhart
    John L. Cameron
    Jin He
    Christopher L. Wolfgang
    Matthew J. Weiss
    Ammar A. Javed
    Journal of Gastrointestinal Surgery, 2020, 24 : 1590 - 1596
12345